OCHIN Applauds Critical Updates to 42 CFR Part 2 in CARES Act

PORTLAND, Ore., March 27, 2020 /PRNewswire/ — OCHIN strongly supports the long-term updates that were made to 42 CFR Part 2 as part of the larger CARES Act that Congress passed in response to the COVID-19 crisis. The new rule closes an important gap in our nation’s health care system by aligning the laws that govern substance use records with existing HIPAA laws that regulate the exchange of medical records between providers, with informed patient consent.

We believe this change will vastly improve health care coordination, ensuring that the patients who receive behavioral health treatment across the OCHIN network of providers have access to the best possible care.

We are profoundly grateful for all the hard work that’s been done to craft this new rule, including the leadership of Senators Shelley Moore Capito (R-WV) and Joe Manchin (D-WV), Congressmen Earl Blumenauer (D-OR) and Markwayne Mullin (R-OK), and the entire Partnership to Amend 42 CFR Part 2 coalition, of which OCHIN is also a member. We are highly encouraged by this legislative milestone, and what it means for the health and safety of the underserved communities that OCHIN champions.

About OCHIN
OCHIN is dedicated to creating a healthier future in every community. A national nonprofit health IT organization with a 20-year history, OCHIN brings advanced technology, research and services to underserved areas, both urban and rural. A driving force for health equity, OCHIN empowers community health organizations serving lower-income areas so that they can deliver the highest quality care to their patients. Learn more at www.ochin.org.

Contact: Jennifer Stoll, 503-720-9882, stollj@ochin.org

View original content to download multimedia:http://www.prnewswire.com/news-releases/ochin-applauds-critical-updates-to-42-cfr-part-2-in-cares-act-301031159.html

SOURCE OCHIN

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

4 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

4 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

4 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

7 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

10 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

10 hours ago